Clinical Trial Update: Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus [Phase 3]

View source ↗

Summary

Phase 3 study of Difelikefalin in Chinese adults on haemodialysis with moderate-to-severe uremic pruritus has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremic Pruritus

Drugs mentioned

• Difelikefalin (difelikefalin)

Snippet

Sponsor: Vifor Fresenius Medical Care Renal Pharma | Conditions: Uremic Pruritus | Phase 3 | Status: COMPLETED | Results posted: 2025-09-12